Karen B Maynard

US Patent:

20230015268, Jan 19, 2023

Filed:

Sep 12, 2022

Appl. No.:

17/931249

Inventors:

- Murfreesboro TN, US
Matthew Fuller - Murfreesboro TN, US
Gheda Alsaif - Hail, SA
Shannon Smith - Murfreesboro TN, US
Karen Maynard - Murfreesboro TN, US
Anthony Farone - Murfreesboro TN, US

International Classification:

A61K 31/60
A61K 31/352
A61K 31/05
A61K 31/201
A61K 39/395
A61K 31/573
A61K 45/06
A61P 29/00

Abstract:

This disclosure describes compositions including cannabinoids and omega fatty acids and methods of using those compositions including, for example, to treat or prevent inflammation, as an immunosuppressant, and/or as an anti-cancer therapeutic. In some aspects, the cannabinoid is chosen from i) CBC, CBCA, CBD, CBDA, CBDV, CBDVA, CBG, CBGA, CBL, CBLA, CBN, CBNA, THCV, THCVA, and any combination thereof, and ii) an approximately 1:1 equimolar mixture of CBD:CBDA. In some aspects, the omega fatty acid is chosen from an omega-3 fatty acid (such as ALA, DHA, or EPA), an omega-7 fatty acid, or an omega-9 fatty acid.

US Patent:

20210379132, Dec 9, 2021

Filed:

Jun 4, 2021

Appl. No.:

17/338882

Inventors:

- Murfreesboro TN, US
Shannon Smith - Murfreesboro TN, US
Karen Maynard - Murfreesboro TN, US
Elliot Altman - Rockvale TN, US

International Classification:

A61K 36/258
A61K 31/704
A61K 31/522
A61K 31/52
A61K 31/675
A61K 31/7125
A61P 31/22
A61K 31/662

Abstract:

This disclosure describes a composition including the ginsenoside 20(S)-Rg3 (also referred to herein as Rg3) and methods of using such a composition. In some embodiments, the composition may be used to treat or prevent an alpha herpesvirus including, for example, herpes simplex virus (HSV)-1 and HSV-2. In some embodiments, the composition is substantially free of other ginsenosides.